Wolverine Trading, LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $907,609 - $1.14 Million	-7,300 Reduced 13.8%	45,600 $5.7 Million
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $339,990 - $491,550	-3,000 Reduced 5.37%	52,900 $8.36 Million
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $2.42 Million - $3.65 Million	-25,800 Reduced 31.58%	55,900 $7.24 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $3.21 Million - $5.95 Million	47,700 Added 140.29%	81,700 $7.88 Million
Q3 2023 Nov 15, 2023	BUY	$102.5 - $123.59 $584,250 - $704,463	5,700 Added 20.14%	34,000 $4.12 Million
Q2 2023 Aug 23, 2023	SELL	$106.4 - $157.19 $414,960 - $613,041	-3,900 Reduced 12.11%	28,300 $3.24 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $1.82 Million - $2.42 Million	-15,500 Reduced 32.49%	32,200 $4.38 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $2.07 Million - $2.71 Million	20,500 Added 75.37%	47,700 $6.18 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $234,700 - $369,644	3,100 Added 12.86%	27,200 $2.98 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $645,707 - $910,932	10,300 Added 74.64%	24,100 $1.86 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $707,280 - $1.01 Million	-11,200 Reduced 44.8%	13,800 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $316,848 - $407,622	-4,100 Reduced 14.09%	25,000 $2.27 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $468,387 - $656,608	7,100 Added 32.27%	29,100 $2.58 Million
Q2 2021 Aug 06, 2021	SELL	$69.38 - $86.75 $1.56 Million - $1.95 Million	-22,500 Reduced 50.56%	22,000 $1.73 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $404,600 - $946,119	-5,600 Reduced 11.18%	44,500 $3.25 Million
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $4.01 Million - $5.7 Million	-31,900 Reduced 38.9%	50,100 $8.59 Million
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $5.19 Million - $7.03 Million	40,800 Added 99.03%	82,000 $11.6 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $344,100 - $635,290	-3,700 Reduced 8.24%	41,200 $6.7 Million
Q1 2020 May 11, 2020	SELL	$82.38 - $131.64 $6.79 Million - $10.8 Million	-82,400 Reduced 64.73%	44,900 $4.42 Million
Q4 2019 Feb 12, 2020	BUY	$76.53 - $135.58 $9.74 Million - $17.3 Million	127,300 New	127,300 $16.4 Million
Q2 2019 Aug 20, 2019	SELL	$112.21 - $151.95 $24.8 Million - $33.6 Million	-221,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $5.49 Million - $7.81 Million	51,500 Added 30.38%	221,000 $26.3 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $11.1 Million - $16.9 Million	-113,900 Reduced 40.19%	169,500 $18.3 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $14.3 Million - $20 Million	123,700 Added 77.46%	283,400 $45.8 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $5.59 Million - $8.51 Million	-103,500 Reduced 39.32%	159,700 $11.8 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $7.12 Million - $8.48 Million	-149,400 Reduced 36.21%	263,200 $14.6 Million
Q3 2017 Nov 15, 2017	BUY	$35.73 - $47.15 $14.7 Million - $19.5 Million	412,600	412,600 $18.7 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.35 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.17 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$817 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$569 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$557 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account